| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc41f69dd8e0d8521f914b5631f7a36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7df1e0dbb2142312b6608fbce3df41b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_528d97c52dce476ada4244490cafc019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dea788ea89f72688a59de850e9b74bf8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-065 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01J49-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01J49-0036 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01J49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01J49-16 |
| filingDate |
2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576c9564ca46ec31418840f52c38ff89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2c9f3eb757c8a453cd8d773296f784a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82991f5c8abab19c448cd6d0a019aeff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_555924133bd549449541204f89a3e347 |
| publicationDate |
2021-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021096138-A1 |
| titleOfInvention |
Histology guided mass spectrometry |
| abstract |
The use of matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI) to assay feline tissue samples is described. Methods of analyzing a tissue sample may generally comprise generating sample ions directly from the tissue sample using a MALDI ionization source, receiving the ions into a mass spectrometer, identifying at least one inflammatory bowel disease and/or lymphoma related compound in the sample from results from the mass spectrometer, comparing the at least one identified related compound in the sample to one or more known inflammatory bowel disease and/or lymphoma profiles, and identifying at least one condition related to the sample from the comparison of the at least one identified related compound to the one or more known inflammatory bowel disease and/or lymphoma profiles. The mass spectrometer may be a quadrupole mass spectrometer, a time of flight mass spectrometer, an Orbitrap mass spectrometer, or an ion trap mass spectrometer. |
| priorityDate |
2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |